To enhance students ability to interpret data in charts and graphs To discuss basic concepts in epidemiology and science.

Slides:



Advertisements
Similar presentations
International Epidemics Lecture September 23, 2014 B.W. Cue, Jr. (UMB 1969) Outline – An overview of infectious microbes (excluding fungii) Bacterial vs.
Advertisements

Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11): October 17, 2005 © The Author Published by Oxford University.
From: A Regularist Approach to Mechanistic Type-Level Explanation
From: An open day in the metric space
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Fig. 1 Flow chart of the COBRA-light trial and its extension study
From: Global Banking: Recent Developments and Insights from Research*
Fig. 1 Graphical representation
Figure 2. CONSORT flow diagram.
Figure 1. Period–cohort diagram.
Fig 1 Trends in organ donors in the UK, 2000–10
Figure 1. Disposition of study participants, by group. Data are no
Test characteristics of MRI-detected inflammation for the development of arthritis in CSA patients (A) and RA in UA patients (B) during 1-year follow-up.
Figure 1. Forest plot: overall estimate
Error bars represent the mean (s.e.).
Figure 1. Shiga toxin–producing Escherichia coli (STEC) isolates by method of initial detection and STEC serotype, Connecticut, 2000–2009. From: Ten-Year.
pSS: primary SS; Scl: scleroderma.
Figure 3. Examples of tweets classified as ridicule.
Figure 1. Selection of papers.
Fig. 1 Underestimation and lack of sensitivity of T1-weighted fat-suppressed (FS) SPGR sequence in the assessment of BMLs. (A) Sagital T2-weighted.
Fig. 1 Flow chart of study selection
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.
Fig. 1. Geographic locations of Shenzhen and Dongguan
From: Unmasking Masks in Makkah: Preventing Influenza at Hajj
Figure 1. Hepatitis B surface antigen (HBsAg) testing uptake and results among women delivering at Bairo Pite Clinic in Dili, Timor-Leste. From: Prevalence.
Fig 1 Respiratory support escalation strategies for study patients
Fig 1 Perfusion index values at different time intervals in patients with successful and failed blocks. A reference line at PI 3.3 is provided. Horizontal.
Figure 1. Prevalence of undocumented hepatitis C virus (HCV) infection, by age, race, and sex in 4713 emergency department patients, From: Evaluation.
From: A European Disease
Example 14. Schubert, Quartet in G Major, D
Fig. 1 Selection of patients
Fig. 1 Flow diagram of patient selection and study design.
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
From: Estimating the Location of World Wheat Price Discovery
Figure 3. Hypothalamic–Pituitary–Adrenal (HPA)-axis functioning moderates crime exposure: regions of significance on X (crime). The lines represent two.
Figure 1: Time points at which sperm samples were analysed for aneuploidy frequencies in controls and cancer patients From: Sperm aneuploidy frequencies.
Figure 1: Logistic regression showing association of prescribing provider and patient panel characteristics with occurrence of a hospitalization or ED.
Figure 1. Percentage of trainees is represented on the y-axis for each competency/knowledge item represented in the x-axis. Only Poor/Fair (P/F) ratings.
Fig 1 Distribution of GlideScope® videolaryngoscopy and direct laryngoscopy patients from the Paediatric Difficult Intubation Registry. GVL,
Figure 6. RRs for clinical cure rates stratified by different diseases
Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.
Figure 5. Tungiasis: a 21-year-old woman returned from Peru with painful nodules on her toes. From: Illness in Travelers Returned From Brazil: The GeoSentinel.
Figure 3. Changes from baseline in activated CD4+ T cells (% CD4+CD25+) during the 52-week intervention period in the.
Figure 1. Ten chemotherapeutic drugs induce the bacterial SOS response
Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.
Figure 1. Structure of two poxtA-carrying plasmids in E
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1. SpeI-PFGE dendrogram comparing P
Fig. 1 Flow chart of included patients for analyses
Figure 1. Mean log10 cfu/mL versus time profile for each individual drug at 4× MIC against the four VRE ... Figure 1. Mean log10 cfu/mL versus.
Fig. 1 Flow chart for selection of study subjects
Figure 1. Susceptibility of all P
Figure 1. (a) Geographical representation of sample collection area
Figure 1. CONSORT flow diagram
Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.
Figure 1. Sequence comparison of plasmid pG38 (GenBank accession no
Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.
Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.
Figure 1. Trunk and leg fat over study period. LS, log transformed.
Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.
Figure 1. Observed mean (SD) micafungin plasma concentrations.
Figure 1. Biofilm susceptibility to antibiotic treatment
Figure 1. Time–kill curves of M. abscessus CIP
Figure 1. Genetic context of blaNDM-21 on pNDM21_020023
Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.
Figure 1. Rate of PDR in infants according to ARV exposure
Figure 1. Kaplan Meier curves showing crude product limit survival estimates and 95% confidence intervals for time to ... Figure 1. Kaplan Meier curves.
Figure 1. Kaplan–Meier curves showing the impact of the different pretreatment HIV-1 drug resistance categories on the ... Figure 1. Kaplan–Meier curves.
Presentation transcript:

To enhance students ability to interpret data in charts and graphs To discuss basic concepts in epidemiology and science

Gonorrhea global prevalence and reported drug resistance Sean A. Buono et al. J. Antimicrob. Chemother. 2015;70: © The Author Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please

Survival analysis by cryptococcal antigen test result, Multicenter AIDS Cohort and the Women's Interagency HIV Study, 1986–2012. Jennie McKenney et al. Clin Infect Dis. 2015;60: © The Author Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please

 Sensitivity is the ability of a test to detect a positive result in those with a disease or condition  Specificity is the ability of a test to detect a negative result in those without a disease or condition

 Positive Predictive Value (PPV) is the likelihood that when a test is positive, the patient has the disease/ condition

 Negative Predictive Value (NPV) is the likelihood that when a test is positive, the patient has the disease/ condition

 The P-value is the probability that a finding is due to chance  When the P-value is less than 0.05 (5%), scientists call that “statistically significant”

 Statistical significance is when a finding is unlikely to be due to chance

Positive predictive value P-value Sensitivity Negative predictive value Specificity Significance Disease+, test+ Test+, disease+ Chance Disease-, test- Test-, disease- Probability